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Introduction 
Arginase is a manganese-containing protein (1,2) 
of molecular weight 138,000 (3) found in significant 
concentration only in the liver of ureotelic animals. 
Smaller amounts are present in the mammary gland, 
testis, kidney, and skin while traces occur in other 
tissues and organs (4,5). The specific action of this 
enzyme is to catalyze the hydrolytic cleavage of 
L-arginine to L-ornithine and urea: 
H00C-CHNK2(CH2)CH-NH-CNH0 + HO 
L-arginine 
HOOC-CHNH -(CH ) -CHNH0 + 0=C( NH0 ) 
Ca (Li 
(1) L-ornithine urea 
Despite the important role of arginase in urea 
synthesis and the physiological coupling of the urea 
cycle to other metabolic cycles, there has been no 
study on the effects of anesthetics on the activity 
of this enzyme. 
It is known that hepatic arginase activity in 
the rat is decreased by hypophysectomy and adrena¬ 
lectomy (6,7), and that there is increased activity 
upon the administration of thyroxine (10) and adreno 
cortical and corticotropic hormones (6-9). Hepatic 
arginase activity is also enhanced in the fasting 
rat (ll) and in the rat maintained on a high protein 
diet (12,13,14), and conversely, diminished in the 
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animal with restricted dietary protein (15). There 
is thus an intimate relationship between many hormones 
and the enzymes of protein metabolism. Since 
anesthetics are known, to modify the serum level of 
thyroxine and adrenocortical substances (16,17), it 
would seem important to study the direct effects of 
anesthetics on arginase activity. 
It has been demonstrated that there is a 
decrease in hepatic arginase activity in patients who 
died in hepatic coma (18). On the other hand, serum 
arginase activity, which normally is negligible, is 
elevated and parallels glutamic oxaloacetic trans¬ 
aminase in subjects with hepatocellular damage (19,20). 
Considering the association of halothane anesthesia 
with hepatic necrosis (21,22) and that other anes¬ 
thetics may be hapatotoxic, a knowledge of the direct 
effects of anesthetics on arginase activity might be 
important. 
This study was designed to determine the 
effects of two commonly used anesthetics, diethyl 
ether and halothane, on arginase activity in vitro. 
The simplest system possible, involving the intro¬ 
duction of a known amount of anesthetic into a test 
tube containing only purified enzyme and substrate 
was employed. 
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Materials and Methods 
I. Arginase Unit: A unit of arginase activity is 
that amount of arginase which in i minute at 25 degrees 
C. and pH 9.5 (by glass electrode) and with a substrate 
concentration of 0.285 M will decompose i micromole 
(10~ mole) of arginine, i.e., will liberate 1 
micromole of urea (0.06 mg.) containing 0.028 mg. 
of nttrogen (23). 
II. Apparatus: Klett-Summerson photometer. 
III. Reagents: 
* 
Arginine solution 0.85 M, pH 9.5 
Arginase* 
Sulfuric-phosphoric acid mixture - 90 cc. of 
concentrated sulfuric acid and 270 cc. of 
syrupy phosphoric acid adjusted to 1 liter 
with water. 
Alpha-isonitrosopropiophenone - 3% solution 
in 95% ethyl alcohol. 
Maleic acid-MnSO^ solution - 0.05 M maleate, 
0.05 M MnSO^, pH 7.0. Maleate keeps high 
concentrations of manganese ions in solution, 
thereby preventing the deposition of man¬ 
ganese chloride. 
Standard urea solution 0.4 millimole. 
IV. Procedure: 
There are several reasons for using a high 
* L-arginine HCL, purity greater than 99% and 
arginase purified from bovine liver with stated 
activity of approximately 20 units per mg. obtained 
from Sigma Chem. Co. 
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concentration of substrate. Van Slyke (24,25) found 
that the kinetic action of arginase is described by 
the following equation: 
(2) S = | (l/K1 log a/a-x + x/K2) 
where S = the concentration of the enzyme 
t = time of reaction 
a = initial concentration of the substrate 
x = decrease in substrate concentration at time t 
K^= velocity constant of the combination of 
enzyme and substrate 
K0= velocity constant of the decomposition of 
the combined substrate 
Enzymatic decomposition of arginine involves first 
the combination of enzyme and substrate and then the 
decomposition of this complex. At high substrate 
concentration, the time involved in the formation of 
the enzyme-substrate complex is insignificant com¬ 
pared with the time taken by the decomposition. 
Van Slyke showed that under these conditions, for 
a limited reaction time (t = 5 minutes), a/a-x 
essentially equals unity and Equation 2 simplifies to 
(3) E = x/K?t 
The amount of urea formed (x) is then directly 
proportional to the amount of arginase (E). 
Secondly, Van Slyke (24,25) and Hunter (26) 
demonstrated that ornithine, which is formed with 
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urea by the action of arginase on arginine, competes 
with arginine for the active group of the enzyme, 
and thus inhibits it competitively. At a high 
concentration of arginine, however, the inhibitory 
action resulting from the formation of ornithine 
would be insignificant. 
A procedure for assaying arginase activity 
slightly modified from that described by Van Slyke 
and Archibald (23) and by Greenberg (29) was used. 
Since activitation of arginase requires the presence 
of manganese ion (1,3,27,28), the enzyme solution was 
prepared by incubating 2.5 mg. of the enzyme in 2.5 cc. 
of maleate-manganese sulfate solution for 4 hours at 
37 degrees C. This volume was then diluted to 1:50 
with maleate-manganese sulfate solution. 
1 cc. of the diluted enzyme solution, containing 
0.05 mg. of arginase, prepared just prior to use 
was added to 0.5 cc. of the arginine solution in a 
15 x 125 ram. Fyrex test tube. The substrate con¬ 
centration by dilution became 0.285 M while the pH 
remained at 9.5, near optimum for arginase, by action 
of the buffer in the substrate solution. The test 
tube was sealed with parafilm and the reagents 
thoroughly mixed. The reaction was carried out at a 
constant temperature of 25 degrees C. The action 
of arginase was stopped at the appropriate time by 
the addition of 8.5 cc. of sulfuric-phosphoric 
acid mixture. 
The amount of urea formed was determined by 
the method described by Archibald (30). To each 
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tube 0.5 cc. of the 3fo solution of alpha-isoni- 
trosopropiophenone was added. After the contents 
were mixed, the tube was stoppered and heated for 1 
hour in a boiling Welter bath. The tube was cooled 
for 15 minutes in the dark because the color developed 
is photolabile. The optical density was read at 
a wavelength of 540 mp against the reagent blank set 
at zero. The control was prepared by adding the 
acid before the enzyme solution. Urea standards 
were prepared with the sulfuric-phosphoric a,cid 
mixture. 
To establish that Equation 3 pertains for 
a reaction time longer than 5 minutes, a series of 
10 runs, with determination of urea concentration 
at 2 minute intervals up to 20 minutes, was done. 
The graph of the reaction plotting arginase activity 
as a function of time is shown in figure 1. 
In the experimental set up, a calculated 
amount of volatile anesthetic was delivered by a 
glass pipette into the test tube of arginase- 
arginine solution for the duration of the desired 
reaction time. The Heidbrink-Vernitrol vaporizer, 
set to deliver diethyl ether at 2 volume percent, 
halothane at 1 volume percent, and cyclopropane at 
25 volume percent in a total flow of 2 liters per 
minute was used. This rate of flow was the lowest 
at which the desired amount of anesthetic could be 
accurately delivered. Oxygen or helium served as 
the diluent. However, this attempt at introducing 
a physiologically effective concentration of anesthe¬ 
tic into the reagents was abandoned when the bubbling, 
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regardless of the anesthetic or diluent used, 
inactivated the enzyme system. 
An alternative method was to introduce the 
anesthetic in liquid state into the test tube 
containing the arginase-arginine solutions. Ether, 
in doses of 0.1 cc. and 0.2 cc.} was used. Immediately 
after introduction of the ether, the tubeTsealed 
with x^arafilm. The amount of urea formed in 2, 4, 
6, 8, and 10 minutes was determined. A series of 8 
runs, using each of the two coneentrations of ether, 
with suitable controls and under the conditions 
described above, were carried out. A series of 8 runs, 
using 0.1 cc. of halothane, and two series, con¬ 
sisting of runs of 5 and 3 to 4, using 0.2 cc. of 
halothane were similarly carried out. The enzyme 
solution was prepared from the same batch of arginase 
with the exception of the last two series when the 
original batch was used,up. The two series using 
halothane 0.2 cc. consisting of 5 runs and of 3-4 
runs are designated A and B, respectively. 
V . Calculation of Anesthetic Concentration: 
ether 0.7077 
0.1 cc. = 70 mg. 
70 mg./1.5 cc* = 4.6 gm.> 
0.2 cc. ss 9.2 gm.fo 
halothane 
1.86 
0.1 cc. = 186 mg. 
186 mg./l.5 cc. = 12.4 gm.fo 
0.2 cc. = 24.8 gtn.fo 
* 1.5 cc. of arginase and arginine solution. 
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Table I. Arginase Activity with 0.1 cc. of Ether 
Micromoles of Urea 
Time 
(minutes) 
Ether Control Time Ether Control 
2 0.73 0.62 8 2.69 2.63 
0.50 0.50 2.58 2.74 
0.62 0.45 2.63 2.52 
0.67 0.78 2.63 2.24 
0.73 0.39 2.74 2.74 
0.62 0.67 2.63 2.63 
0.78 0.84 2.69 2.46 
0.45 0.39 2.58 2.35 
ave. 0.63 0.58 2.64 2.53 
4 1.47 1.47 10 3.25 3.19 
1.47 1.47 3.02 3.02 
1.47 1.23 3.14 2.86 
1.57 1.47 3.42 2 .91 
1.34 1.12 3.14 2.63 
0.90 1.18 2.86 2.97 
1.34 0.67 2.97 2.86 
1.57 0.90 2.91 3.08 
ave. 1.39 1.18 3.08 2.94 
6 2.07 1.62 
1.51 1.85 
1.96 1.90 
1.96 2.02 
1.96 2.07 
2.07 1.85 
2.18 2.02 
1.90 2.18 
ave. 1.95 1.93 
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Table II. Arginase Activity with 0.2 cc. of 
Micromoles of Urea 
Time 
(minutes) 
Ether Control Time Ether 
2 0.56 0.56 8 2.69 
1.01 0.84 2.80 
0.84 1.06 3.08 
1.01 0.67 2 .80 
0.56 0.56 1.96 
0.56 0.67 2.24 
0.67 0.78 2.52 
0.84 0.78 2.74 
ave. 0.75 0.74 2.60 
4 1.51 1.96 3.14 
1.29 1.18 2.86 
1.23 1.23 3.25 
1.29 1.23 2.97 
1.40 1.40 2.41 
1.23 1.23 3.19 
1.57 1.01 3.36 
1.23 1.06 3.30 
ave. 1.34 1.28 3.06 
6 2.46 2.63 
2.13 2.80 
2.02 1.96 
2.02 2.07 
2.18 1.90 
1.85 2.02 
1.85 2.02 
2.07 2.13 
ave. 2.07 2.19 
Ether 
Control 
2.58 
3.08 
2.80 
3.14 
1.96 
2.35 
2.46 
2.63 
2.62 
3.25 
2.97 
3.36 
3.30 
3.86 
3.64 
3.42 
3.46 
3.40 
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Table III. Arginase Activity witn 0.1 cc. of naXothane 
Micromoles of Urea 
Time Halothane Control 
(minutes) 
2 0.73 0.73 
0oS2 0.62 
0.78 0.73 
0.34 0.39 
0.45 0.73 
0.95 0.67 
0.34 0.84 
1.01 0.73 
ave. 0.71 0.68 
4 1.23 1.47 
1.79 1.80 
1.34 1.57 
1.47 1.80 
1.23 1.23 
1.51 1.74 
1.57 1.57 
1.51 1.23 
av e» 1.45 1 ♦ o 5 
6 2.13 1.85 
2.02 2.07 
2.02 2.30 
2.13 2.13 
1.74 1.74 
2.18 2.18 
2.13 1.90 
1.80 2.02 
. 2.01 2.01 
Time Halethane Control 
8 3.25 3.47 
2.63 2.80 
2.30 3.08 
2.69 2.63 
2.63 2.80 
2.80 3.02 
1 .So 2.52 
2.24 2.69 
2.55 2.87 
10 3.47 3.53 
3.30 3.36 
3 o 36 3.92 
2.97 3.30 
3.92 3.86 
3.25 3.64 
3.70 3.70 
3.70 3.75 
3.45 3.63 
ave 
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Table IV. Arginase Activity with 0.2 cc. of Halothane (A) 
Micromoles of Urea 
Time 
(minutes) 
Halothane Control Time Halothane Control 
2 0 .4o 0.56 8 1.57 2.63 
0.45 0.45 2.24 2.41 
0.45 0.50 2.35 2.80 
0.45 0.56 1.62 2.80 
0.62 0.78 2.02 2.41 
ave. 0.48 0.57 1.96 2.61 
4 0.73 0.84 10 2.69 2.97 
0.45 1.06 2.18 2.63 
1.12 1.29 2.69 3.08 
0.90 1.23 2.74 3.08 
1.12 1.40 3.02 3.64 
ave. 0.86 
CD
 
•
 
•HI
 2.66 3.08 
6 1.57 1.80 
1.34 1.62 
1.40 2.07 
1.62 2.18 
1.40 1.79 
ave. 1.47 1.89 
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Table V. Arginase Activity with 0.2 cc. of Halothane (B) 
Micromoles of urea 
Time Halothane Control Time Halothane Control 
(minutes) 
2 0.84 1.12 8 3.53 4.54 
0.84 1.12 3.53 4.98 
1.06 1.47 2.97 4.09 
3.42 3.53 
ave. 0.91 1.23 3.36 4.28 
4 1.23 2.35 10 5.56 0.99 
1.90 2,63 4.98 5.38 
1.74 1.68 3.81 5.54 
ave . 1.62 2.22 4.81 5.63 
6 2.52 3.36 
3.30 3.53 
2.13 3.02 
2.86 3.81 
ave. 2.70 3.43 
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The average values of the amount of urea 
formed, were plotted against time in figures 11 - V, 
The lines that best fit the data as described by 
the following equationsvere also plotted in figures 
il-V. 
ether 0.1 
control 
cc. y=0.10 + 
y=0.01 + 
0.31x 
0.30x 
ether 0.2 
control 
ec. y= 0.21 
y=0.05 + 
+ 0.29x 
0.33x 
halothane 
control 
0.1 cc, y=0.1i + 
y= -0.02 
0.31x 
+ 0.36x 
halothane 
control 
0.2 cc.(A) y= ”0. 
y= 0. 
15 + 0.27x 
07 + 0„32x 
halothane 
control 
0.2 cc.^B) y= 0.05 
y= 0.36 
+ 0.44x 
+ 0.50x 
where x = time in minutes 
y = micromole of urea 
Estimation of Arginase Activity 
Since the reaction time was carried out up 
to 10 minutes, the unit of arginase activity was 
determined from the above equations by dividing y 
into 10 when x = 10. Table VI summarizes the results. 
Table VI 
Unit Activity* Change in Activity 
ether 0.1 cc. 0.32 6.7% inc. 
control 0.30 
ether 0.2 c c. 0.31 8.8% dec. 
control 0.34 
halo. 0.1 cc. 0.32 11.1% dec. 
control 0.36 
halo. 0.2 cc. (A) 0.26 21.2% dec. 
control 0.33 
halo. 0.2 cc. IB) 0.46 14.8/0 dec. 
control 0.54 
* in the 0.05 mg. of arginase 
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For each time interval when the control and 
experimental groups using ether, 0.1 cc. and 0.2 cc., 
and halothane 0.1 cc. were compared with the "t" 
test, no statistically significant differences were 
found, nowever, with halothane 0.2 cc. (A and B), 
there was a statistically significant inhibition of 
arginase activity. 
Discussion 
There are many ways in which a drug may 
act on an enzyme and alter its activity. Among them, 
two mechanisms are relevant to the present inves¬ 
tigation: 
1. The drug alters the oxidative state of the 
manganese ion, which is the metallic coenzyme of 
arginase. 
2. The drug forms an insoluble complex with the 
manganese ion. 
These mechanisms have in common the effect of 
making the metallic coenzyme unavailable to the 
protein moiety, thereby inactivating arginase. 
The attempt to introduce a physiologically 
effective concentration of anesthetic into the test 
tube containing the arginase-arginine solution had 
to be abandoned when the effect of the bubbling, 
regardless of the anesthetic or diluent used, in¬ 
activated the enzyme system. The time required for 
the inactivation, which was essentially complete, 
was less than 2 minutes. The temperature and pH 
were not altered, and even if there were slight 
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changes in either or both factors, one would not 
expect complete inhibition, it is possible that the 
effect of bubbling on the arginase-arginine solution, 
by increasing the exposure of this solution to air, 
resulted in the oxidation of the manganese ion which 
is essential for enzyme activity. 
He Herman (l) visualizes arginase as con¬ 
taining a metallic component which may be oxidised 
or separated from the rest of the molecule by 
oxidizing agents. He postulates that activators, 
which include Mn , Co , Mi , and Fe replace 
that component when it is lost. However, in 
4*4* 
highly purified arginase, only Mn has been demon¬ 
strated to be the activator. Dixon and Webb (3l) 
explain this phenomenon by the fact that a metal 
itself not an activator may displace the true 
activating metal so as to permit it to function. 
Other substances, such as Zn++and KMrC°A (3) and 
HCN (l) inhibit arginase activity. 
Iron, cobalt and nickel with atomic numbers 
of 26, 27, and 28, respectively, resemble each other 
closely in physical and chemical properties by nature 
of the electron configuration of their respective 
atoms9 Thus, any of this triad is similar enough to 
manganese to substitute for it, or to serve in the 
role postulated by Dixon and Webb, and thereby 
activate arginase. On the other hand, zinc with 
atomic number 30, has different properties and pre¬ 
sumably competes with the manganese ion as the 
metallic component in the arginase molecule and 
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thereby acts as an inhibitor. 
KMrfJ0^ is postulated by Greenberg et al ^ 3) 
to decrease arginase activity because of its oxi¬ 
dative effect on the manganese ion. riCN, because of 
its strong tendency to react with metal ions, may 
inhibit arginase by forming a complex with the man¬ 
ganese ion. 
Therefore, the common effect of the various 
mechanisms (by displacement, combination to form a 
complex, and oxidation) in which Zn++, I1CN and 
KMn^O^ inactivate arginase activity is to make the 
manganese ion unavailable to the enzyme molecule. 
The effect of aeration by bubbling presumably 
inhibits arginase by the oxidation of the manganese 
ion. 
Diethyl ether has been shown to be asso¬ 
ciated with the inhibition of at least three enzyme 
systems: the enzyme(s) responsible for the meta¬ 
bolism of pentobarbital (32), carbonic anhydrase 
V33), and lactic dehydrogenase (34). The suggestion 
was made in one of these studies (34) that the 
inhibitory effects of ether may possibly be related 
to interactions of anesthetics with proteins (35). 
While arginase has been shown to be a typical 
protein on the basis of its amino acid composition 
by column chromatography (3), the results of this 
investigation show that ether does not alter arginase 
activity in vitro. That a drug may inactivate 
arginase by binding the protein moiety, however, has 
been demonstrated by the inhibitory action of 
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2 imini=l,2, f luorenocjuinone, an antimetabolite (.36). 
It is significant that the concentrations of ether 
employed (4.8 gm.^ and 9.2 gm.fo) are considerably in 
excess of those known to be effective in vivo. 
Since such high concentrations of ether in the present 
in vitro experiments demonstrated no effect on arginase 
activity, it can be assumed that more physiological 
concentrations of ether will not alter arginase 
activity in vivo. That arginase obtained from sources 
other than bovine liver will reach differently to 
ether appears improbable. 
A statistically significant inhibitory action 
of halothane vbromochlorotrifluroethane) in con¬ 
centration of 24.8 gm.% but not of 12.4 gm.> on 
arginase activity was demonstrated, noth concen¬ 
trations are far in excess of the physiological 
in vivo concentrations. The mechanism is not clear. 
Although halothane is a highly stable substance (37), 
it may be that at the high concentration used enough 
free chlorine is available to react with the manga¬ 
nese ion in the enzyme molecule to form insoluble 
manganese chloride. Such inhibition, however, 
indicates no biochemical significance. 
Summary 
High concentrations of diethyl ether do not 
result in inhibition of bovine arginase in vitro 
while high concentration of halothane inhibits the 
enzyme. While such inhibition is statistically 
significant, it is of no biochemical significance. The 
effect of bubbling the arginase-arginine solution is 
discussed. 
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